Cargando…

Right atrial appendage firing in atrial fibrillation

BACKGROUND: The role of atrial fibrillation (AF) drivers located at the left atrium, superior vena cava, crista terminalis and coronary sinus (CS) is well established. While these regions are classically targeted during catheter ablation, the role of right atrial appendage (RAA) drivers has been inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Baptiste, Florian, Kalifa, Jérôme, Durand, Cyril, Gitenay, Edouard, Bremondy, Michel, Ayari, Anis, Maillot, Nicolas, Taormina, Antonio, Fofana, Aicha, Penaranda, Guillaume, Siame, Sabrina, Bars, Clément, Seitz, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618623/
https://www.ncbi.nlm.nih.gov/pubmed/36324749
http://dx.doi.org/10.3389/fcvm.2022.997998
Descripción
Sumario:BACKGROUND: The role of atrial fibrillation (AF) drivers located at the left atrium, superior vena cava, crista terminalis and coronary sinus (CS) is well established. While these regions are classically targeted during catheter ablation, the role of right atrial appendage (RAA) drivers has been incompletely investigated. OBJECTIVE: To determine the prevalence and electrophysiological characteristics of AF driver’s arising from the RAA. MATERIALS AND METHODS: We conducted a retrospective analysis of clinical and procedural data of 317 consecutive patients who underwent an AF ablation procedure after bi-atrial mapping (multipolar catheter). We selected patients who presented with a per-procedural RAA firing (RAAF). RAAF was defined as the recording of a sustained RAA EGM with a cycle length shorter than 120 ms or 120 < RAAF CL ≤ 130 ms and ratio RAA CL/CS CL ≤ 0.75. RESULTS: Right atrial/atrium appendage firing was found in 22 patients. The prevalence was estimated at 7% (95% CI, 4–10). These patients were mostly men (72%), median age: 66 yo ± 8 without structural heart disease (77%). RAAFs were predominantly found in paroxysmal AF patients (63%, 32%, and 5% for paroxysmal, short standing and long-standing AF, respectively, p > 0.05). RAAF median cycle length was 117 ms ± 7 while CS cycle length was 180 ms ± 10 (p < 0.01). CONCLUSION: In 317 consecutive AF ablation patients (22 patients, 7%) the presence of a high-voltage short-cycle-length right atrial appendage driver (RAAF) may conclusively be associated with AF termination. This case series exemplifies the not-so-uncommon role of the RAA in the perpetuation of AF.